PATENT CLAIM ANALYSIS

Application Number: 16006137
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "415000"]

Abstract:
The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.

Claim (Index 4):
The method of  claim 2 , wherein the cancer is lymphoma.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.53659
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11720776', '14441750', '14682504', '11226655', '14113718']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7386017355221591
- 35 USC 102 Novelty (BERT): 0.4993335272583085
- Combined Prediction Score: 0.7146749146957742
- Mean Citation Score: 159.175248
- Max Citation Score: 164.59892
- Similarity Product: 98.0462437429714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test